This filing is procedural and does not convey any trading signal. Monitor future Form 4 filings for any insider transactions by Preston that could indicate conviction in the stock.
ELAN drugs
ELAN drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 4 $25.31entry
- T+1 · 12d ago −6.44%α −2.03% · $23.68
- T+5 · 6d ago +4.62%α +5.54% · $26.48
- T+8 · todayOpen
- T+20 · in 16d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Jamie Preston, newly appointed EVP and Chief People Officer of Elanco Animal Health, filed a Form 3 initial statement of beneficial ownership. This is a routine administrative filing triggered by the officer's appointment and contains no financial data or trading activity.
Key Facts
- Jamie Preston filed a Form 3 as a new reporting person of Elanco Animal Health Inc.
- Preston holds the title EVP, Chief People Officer.
- The filing includes a Power of Attorney (Exhibit 24) authorizing representatives to execute future Section 16 filings.
- No beneficial ownership amounts or securities transactions are disclosed in the filing.
Financial Impact
No financial impact; routine initial ownership statement with no disclosed holdings or transactions.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0002162777-26-000002 |
| Document: 0002162777-26-000002-index-headers.html | 0002162777-26-000002 |
| Document: 0002162777-26-000002-index.html | 0002162777-26-000002 |
| Document: 0002162777-26-000002.txt | 0002162777-26-000002 |
Track record
19 reports on ELAN
5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +15.03% at T+5 after the May 19, 2026 report. 9 of 10 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $26.68 Now $26.41 −1.01% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $26.78 Now $26.41 −1.38% settles Feb 11
- Nov 6, 202610d ago 8-K Bullish 6/10 Entry $25.74 Now $26.41 +2.60% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $23.68 Now $26.41 +11.53% settles Feb 3
- Nov 3, 202613d ago 3 Neutral 1/10 Viewing Entry $25.31 Now $26.41 +4.35% settles Feb 2
- Oct 14, 20264w ago Institutional Cluster Bullish 4/10 Entry $23.54 Now $26.41 +12.19% settles Jan 12
- Sep 11, 20269w ago Press Release Neutral 1/10 Entry $23.17 Now $26.41 +13.98% settles Dec 7
- Aug 21, 202612w ago Insider Cluster Bullish 6/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 21, 202612w ago Insider Cluster Bullish 4/10 Entry $24.42 Now $26.41 +8.15% settles Nov 17
- Aug 18, 202612w ago Insider Cluster Bullish 4/10 Entry $24.50 to $26.50 Now $26.41 +7.80% ▲ +8.16% +9.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers